Churchill Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Churchill Management's AMGN Position: Q3 2022 in Review
Churchill Management sold out of Amgen (AMGN) in Q3 2022, closing a stake of 43,931 shares — an estimated $10.7M sold.
Churchill Management first reported a position in AMGN in Q1 2018 and held it in 8 quarters. The position peaked at $25.2M in Q4 2018. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Churchill Management reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
- Churchill Management sold 43,931 Amgen shares in Q3 2022, an estimated $10.7M.
- Churchill Management first reported a position in Amgen in Q1 2018 and held it in 8 quarters.
- Churchill Management's Amgen position peaked at $25.2M in Q4 2018.
- 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Churchill Management's 13F filing for Q3 2022, filed 11 Oct 2022.